Introducing our latest innovation in diagnostic technology - the Lateral Immunoassay. This cutting-edge immunoassay platform offers a rapid, accurate, and convenient solution for healthcare professionals and laboratories to detect a wide range of analytes, including infectious diseases, cardiac markers, and hormonal levels. The Lateral Immunoassay utilizes lateral flow technology to provide results within minutes, making it ideal for point-of-care testing and emergency situations. Its user-friendly design and simple operational steps make it a valuable tool for healthcare providers in various settings, from hospitals and clinics to remote and resource-limited areas. With the Lateral Immunoassay, healthcare professionals can quickly and confidently diagnose patients, monitor treatment efficacy, and make informed decisions for patient care. Its high sensitivity and specificity ensure reliable results, while its compact size and portability make it a versatile solution for on-the-go testing. We are committed to advancing healthcare through innovation, and the Lateral Immunoassay represents our dedication to providing state-of-the-art diagnostic tools that improve patient outcomes and enhance healthcare delivery. Join us in revolutionizing the way immunoassays are performed with the Lateral Immunoassay – the future of rapid, reliable, and accessible diagnostic testing.

Beijing Beier Bioengineering Co., Ltd., a high-tech enterprise in China specializing in the development and production of in vitro diagnostic reagents, has recently introduced a new Rtk Antigen Self T

Beijing, China - In a groundbreaking development, researchers at Beijing Beier Bioengineering Co., Ltd. have announced a major breakthrough in the fight against Treponema Pallidum, the bacterium that